The accuracy of the cancer antigen (CA)–125 test in predicting ovarian cancer varies by ethnicity, primarily due to factors like age and comorbidities rather than ethnicity itself. General ...

Current treatment guidelines recommend using cancer antigen-125 (CA-125) as a diagnostic marker for ovarian cancer recurrence, but a recent study suggests CA-125 has poor concordance with progressive ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American Indian ...

It’s been a challenge for researchers to identify risk factors for ovarian cancer compared to other cancer types. More than 49,000 eligible participants were identified for a new study of PTSD and ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to health ...

Epithelial ovarian carcinoma is the most common type of ovarian cancer. Germ cell tumors often affect teenagers and young ...

Preliminary results of a phase II study to evaluate gefitinib (ZD1839) combined with paclitaxel (P) and carboplatin (C) as second-line therapy in patients (pts) with ovarian carcinoma (OC) Conclusions ...

(HealthDay News) — Salpingectomy alone may be a risk management option for women at hereditary risk of ovarian cancer, according to a review published in the May issue of Cancer Prevention Research.

—This expert discusses recent trends in VTE among ovarian cancer patients—progress to date and work that remains to be done. Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and ...

Add Yahoo as a preferred source to see more of our stories on Google. Watch: Researchers say a medical tampon could be a "game changer" in diagnosing ovarian cancer, as ITV News Meridian's Kara Digby ...